HOUSTON, TEXAS / ACCESS Newswire / April 14, 2025 / CLS Health has expanded its specialty care offerings with the launch of full-spectrum ophthalmology and optometry services at its Clear Lake Campus.

UPPSALA, SWEDEN / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation of the first quarter report for 2025 on April 22, ...

Dual Trials Accelerate VELDONA® Toward Rare Disease Market EntryBridging Strategy Aims to Fast-Track U.S. Regulatory Approvals SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos, Inc.

Seasoned payments leader to drive innovation, compliance, and patient-centric strategies in healthcare finance. GAITHERSBURG, MD / ACCESS Newswire / April 14, 2025 / CERTIFY Health, a leader in ...

Russell Abberley, Vice President and General Manager of Amgen UK and Ireland, has been confirmed as ABPI President-elect, ...

ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today ...

SmiLe Venture Hub is supporting the development and launch of the new OYSTER Incubator, designed to accelerate health and life science innovation in Finland. Drawing on its deep expertise in fostering ...

Dr Despina Moschou, an expert in diagnostic devices based in the University of Bath’s Department for Electronic & Electrical Engineering, has been elected a Fellow of EAMBES, a leading medical and ...

OAKLAND, CA / ACCESS Newswire / April 14, 2025 / World-renowned pioneers in psychedelics and neuroscience - including ...

Private Placement of US$6 Million to fund additional pre-clinical research, Phase 1 and Phase 2a clinical studiesUS$20 Million additional option included in Private Placement to fund the Phase 3 ...

SHELTON, CT / ACCESS Newswire / April 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum ...

Delay in MMJ Biopharma Cultivation’s Application Sparks Calls for DEA Accountability and Reform "This isn't just a case of bureaucratic red tape or administrative lag-this appears to be a deliberate ...